603939 益丰药房
2026/09 - 九个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)11.51415.01314.89115.38315.739
总资产报酬率 ROA (%)5.0626.0575.8676.2526.626
投入资产回报率 ROIC (%)6.0867.1677.0107.6117.995

边际利润分析
销售毛利率 (%)39.74339.35640.12038.20939.529
营业利润率 (%)11.18610.0439.1599.0979.482
息税前利润/营业总收入 (%)11.56110.6359.7939.4029.968
净利润/营业总收入 (%)8.3427.4946.8696.9997.158

收益指标分析
经营活动净收益/利润总额(%)96.66993.79795.68496.763100.034
价值变动净收益/利润总额(%)4.0385.0784.9542.0800.366
营业外收支净额/利润总额(%)-0.7000.109-0.979-0.844-0.429

偿债能力分析
流动比率 (X)1.5601.4321.2591.0761.095
速动比率 (X)1.1701.0370.8990.7380.721
资产负债率 (%)51.23554.90859.27256.71756.652
带息债务/全部投入资本 (%)37.64442.52944.67039.31638.394
股东权益/带息债务 (%)147.779118.179101.354125.160129.685
股东权益/负债合计 (%)89.01677.18564.68671.62071.771
利息保障倍数 (X)25.56118.29113.55024.64218.913

营运能力分析
应收账款周转天数 (天)25.57330.09431.88431.73326.438
存货周转天数 (天)106.685111.339104.14195.72299.615